Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

1(25.0%)

Phase 2

1(25.0%)

Phase 1

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(1)

Phase 2(1)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05518240Unknown

Comparison of Solitaire to Embotrap to Treat Large Vessel Occlusion in Acute Ischemic Stroke (SOLTRAP Study)

Role: lead

NCT04429867Phase 4Unknown

Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease

Role: lead

NCT02618031Phase 1Completed

The Capillary Index Score Trial

Role: collaborator

NCT02446587Completed

Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

Role: collaborator

NCT01728649Not ApplicableWithdrawn

Reperfusion With Cooling in Cerebral Acute Ischemia II

Role: lead

NCT02411877Phase 2Withdrawn

REperfusion With Cooling in CerebraL Acute IscheMia II

Role: lead

All 6 trials loaded